Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative cases

BACKGROUND Germinomatous germ cell tumor is highly sensitive to chemoradiotherapy; patients are expected to survive for decades. Many radiation-induced malignant gliomas (RIMGs) occur >10 years after radiotherapy. Standard therapy for RIMGs has not been established because of the lesion’s rarity,...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurosurgery. Case lessons Vol. 6; no. 16
Main Authors Tsukamoto, Yoshihiro, Natsumeda, Manabu, Takahashi, Haruhiko, Ueno, Asuka, Sakai, Kiichi, Shida, Kazuki, Seto, Hiroki, Saito, Taiki, Shibuma, Satoshi, Nakayama, Yoko, Tanaka, Yuki, Nakano, Toshimichi, Ohta, Atsushi, Maruyama, Katsuya, Okada, Masayasu, Eda, Takeyoshi, Seki, Yasuhiro, Yoneoka, Yuichirou, Shimizu, Hiroshi, Okamoto, Kouichirou, Kakita, Akiyoshi, Oishi, Makoto
Format Journal Article
LanguageEnglish
Published American Association of Neurological Surgeons 16.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BACKGROUND Germinomatous germ cell tumor is highly sensitive to chemoradiotherapy; patients are expected to survive for decades. Many radiation-induced malignant gliomas (RIMGs) occur >10 years after radiotherapy. Standard therapy for RIMGs has not been established because of the lesion’s rarity, the patient’s shorter survival period, and the risk of radiation necrosis by repeat radiation. OBSERVATIONS Two patients, a 32-year-old man and a 50-year-old man, developed glioblastomas more than 20 years after radiation monotherapy for germinoma with or without mature teratoma. The first patient showed a tumor in the left frontotemporal region with disseminated lesions and died 2 months after partial resection of the tumor without responding to the chemotherapy with temozolomide and bevacizumab. Methylation classifier analysis classified the pathology as closest to diffuse pediatric-type high-grade glioma, Rtk1 subtype. The second patient showed a tumor mass in the brainstem and left cerebellar peduncle, which worsened progressively during chemotherapy with temozolomide and bevacizumab. The tumor transiently responded to stereotactic radiotherapy with the CyberKnife. However, the patient died of RIMG recurrence-related aspiration pneumonia 11 months after the biopsy. Methylation classifier analysis classified the pathology as closest to infratentorial pilocytic astrocytoma. LESSONS Chemoradiotherapy may improve the survival of patients with RIMGs. Furthermore, molecular features may influence the clinical, locoregional, and pathological features of RIMG.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Disclosures Dr. Tsukamoto reported honoraria for educational lecture from Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Eisai Co., Ltd. outside the submitted work.
INCLUDE WHEN CITING Published October 16, 2023; DOI: 10.3171/CASE23361.
ISSN:2694-1902
2694-1902
DOI:10.3171/CASE23361